Patent · US Active

RAAV-based compositions and methods

US10597656B2 · kind B2 · utility

11Cited by

25References

10Claims

0Family size

Assignee

University of Massachusetts · US

Inventors

Terence Flotte · Holden, US
Christian Mueller · Wiesbaden, DE
Phillip D. Zamore · Marlborough, US

Key dates

Filing date	Aug 9, 2018
Grant date	Mar 24, 2020
Priority date	—
Expiry date	Aug 9, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.